Rui Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rui Zhu has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Wenting Guo
Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8 shared publicationsLei Zhao
Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
7 shared publicationsHuihua Yang
Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6 shared publicationsMiao Liu
Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6 shared publications- Xiaomin Zhang
Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
6 shared publications Linlin Liu
Department of Occupational and Environmental Health, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publications
Latest Publications
- Open Access
Effects of Non-Nutritive Artificial Sweeteners on Gut Microbiota and Host Metabolism and Health-Related Outcomes: A Review
As obesity, diabetes and other diet-related metabolic disorders continue to rise, non-nutritive artificial sweeteners (NASs) are widely used as sugar substitutes in free-sugar reduction and weight-management strategies, but their effects on the gut microbiota, host metabolism and related health outcomes remain debated. To clarify this evidence landscape, this review synthesizes current knowledge on the effects of major NAS on the gut microbiota and host metabolic and health-related outcome. A bibliometric analysis was conducted to characterize the development, knowledge structure and thematic evolution of this research area. For the eight NAS exposure categories included in this review (saccharin, cyclamate, aspartame, acesulfame potassium, sucralose, neotame, neohesperidin dihydrochalcone and mixed NAS), we performed a compound-specific analysis integrating physicochemical characteristics, regulatory status, and research findings from in vitro, ex vivo, animal and human studies on gut microbiota alterations, host metabolic and health-related outcomes. These findings were further compared through four interpretive dimensions: exposure conditions, research model background, outcome assessment and interpretation of discordant results. Current research evidence does not support a class-wide conclusion that NAS are uniformly harmful or safe. To make research findings searchable, we developed the NAS-MAP knowledge graph, an interactive non-nutritive artificial sweetener–microbiota-associated phenotype knowledge graph. Overall, this review consolidates current knowledge, clarifies the sources of inconsistent findings, and provides a framework for more mechanistically informative studies, standardized evidence reporting, and more precise sweetener-, exposure- and population-specific dietary and public health guidance.
Open AccessEffects of Non-Nutritive Artificial Sweeteners on Gut Microbiota and Host Metabolism and Health-Related Outcomes: A Review
As obesity, diabetes and other diet-related metabolic disorders continue to rise, non-nutritive artificial sweeteners (NASs) are widely used as sugar substitutes in free-sugar reduction and weight-management strategies, but their effects on the gut microbiota, host metabolism and related health outcomes remain debated. To clarify this evidence landscape, this review synthesizes current knowledge on the effects of major NAS on the gut microbiota and host metabolic and health-related outcome. A bibliometric analysis was conducted to characterize the development, knowledge structure and thematic evolution of this research area. For the eight NAS exposure categories included in this review (saccharin, cyclamate, aspartame, acesulfame potassium, sucralose, neotame, neohesperidin dihydrochalcone and mixed NAS), we performed a compound-specific analysis integrating physicochemical characteristics, regulatory status, and research findings from in vitro, ex vivo, animal and human studies on gut microbiota alterations, host metabolic and health-related outcomes. These findings were further compared through four interpretive dimensions: exposure conditions, research model background, outcome assessment and interpretation of discordant results. Current research evidence does not support a class-wide conclusion that NAS are uniformly harmful or safe. To make research findings searchable, we developed the NAS-MAP knowledge graph, an interactive non-nutritive artificial sweetener–microbiota-associated phenotype knowledge graph. Overall, this review consolidates current knowledge, clarifies the sources of inconsistent findings, and provides a framework for more mechanistically informative studies, standardized evidence reporting, and more precise sweetener-, exposure- and population-specific dietary and public health guidance.
- 20 December 2025
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 48 (2) , 61
The association of co-exposure to polycyclic aromatic hydrocarbons and phthalates with surrogate indicators of insulin resistance: a panel study
PAHs and phthalates co-exposure may contribute to insulin resistance (IR), but evidence remains limited. In this repeated-measure pilot study of 127 Chinese adults, we assessed urinary metabolites of PAHs and phthalates and five IR surrogate indicators. During each survey, first-morning urine samples were obtained for 4 consecutive days and fasting blood was drawn on the 4th day. We determined 10 urinary PAH metabolites and 10 urinary phthalate metabolites by gas chromatography-tandem mass spectrometer (GC–MS/MS). Linear mixed-effects models (LMEs), Bayesian kernel machine regression (BKMR), and weighted quantile sum (WQS) regression were applied to explore the individual and overall association. After multivariate adjustments, positive associations were found between summed hydroxyfluorene (∑OHFlu), mono-methyl phthalate (MMP), mono-ethyl phthalate (MEP), mono-iso-butyl phthalate (MiBP), mono-n-butyl phthalate (MnBP) and summed phthalates at lag 0 day with one or more of the 5 IR surrogate indices (all P-FDR < 0.05). BKMR and WQS models further revealed that co-exposure to PAHs or/and phthalates mixture was linked to increased surrogate indices of IR, and ∑OHFlu, MiBP, and MnBP were major contributors. Our finding provided novel clues for elevated IR surrogate indicators associated with PAHs and phthalates co-exposure, and highlighted the importance of further monitoring and controlling PAHs and phthalates pollution to prevent the progression of IR. Graphical abstract
- 20 December 2025
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 48 (2) , 61
The association of co-exposure to polycyclic aromatic hydrocarbons and phthalates with surrogate indicators of insulin resistance: a panel study
PAHs and phthalates co-exposure may contribute to insulin resistance (IR), but evidence remains limited. In this repeated-measure pilot study of 127 Chinese adults, we assessed urinary metabolites of PAHs and phthalates and five IR surrogate indicators. During each survey, first-morning urine samples were obtained for 4 consecutive days and fasting blood was drawn on the 4th day. We determined 10 urinary PAH metabolites and 10 urinary phthalate metabolites by gas chromatography-tandem mass spectrometer (GC–MS/MS). Linear mixed-effects models (LMEs), Bayesian kernel machine regression (BKMR), and weighted quantile sum (WQS) regression were applied to explore the individual and overall association. After multivariate adjustments, positive associations were found between summed hydroxyfluorene (∑OHFlu), mono-methyl phthalate (MMP), mono-ethyl phthalate (MEP), mono-iso-butyl phthalate (MiBP), mono-n-butyl phthalate (MnBP) and summed phthalates at lag 0 day with one or more of the 5 IR surrogate indices (all P-FDR < 0.05). BKMR and WQS models further revealed that co-exposure to PAHs or/and phthalates mixture was linked to increased surrogate indices of IR, and ∑OHFlu, MiBP, and MnBP were major contributors. Our finding provided novel clues for elevated IR surrogate indicators associated with PAHs and phthalates co-exposure, and highlighted the importance of further monitoring and controlling PAHs and phthalates pollution to prevent the progression of IR. Graphical abstract
- Open Access
- 2 December 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (3)
Combined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency
Autoimmune factor XIII (FXIII) deficiency is a rare hemorrhagic disease characterized by severe bleeding and a high mortality rate. However, the pathogenesis of this disease remains unclear. FXIII consumption caused by infections is becoming increasingly common. Our clinical investigation, combined with in vivo experiments, revealed that patients and mice with autoimmune FXIII deficiency displayed complement dysfunction and that pathogenic infection and autoantibody generation were positively correlated. Further analysis revealed the presence of combined FXIII-C3 autoantibodies in patients with autoimmune FXIII deficiency. These combined autoantibodies neutralize FXIII, cause bleeding, and form a complex with C3, inhibiting complement activation and complement-mediated adaptive immune responses. Therefore, compromised immune responses increase host susceptibility to pathogenic Candida albicans infections. Consequently, uncontrolled exogenous fungal infections further activate platelets and cause platelet-related CD40 ligand (CD40L) release. By interacting with the CD40 on the B cell surface, the released CD40L further promotes autoreactive B cell activation to produce more autoantibodies, thereby forming a self-amplification loop for the progressive consumption of FXIII. We believe this study provides a perspective on disease pathogenesis and therapeutic guidance for better treatment of autoimmune FXIII deficiency.
- 2 December 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (3)
Open AccessCombined FXIII-C3 autoantibodies elicit bleeding and complement dysfunction in autoimmune FXIII deficiency
Autoimmune factor XIII (FXIII) deficiency is a rare hemorrhagic disease characterized by severe bleeding and a high mortality rate. However, the pathogenesis of this disease remains unclear. FXIII consumption caused by infections is becoming increasingly common. Our clinical investigation, combined with in vivo experiments, revealed that patients and mice with autoimmune FXIII deficiency displayed complement dysfunction and that pathogenic infection and autoantibody generation were positively correlated. Further analysis revealed the presence of combined FXIII-C3 autoantibodies in patients with autoimmune FXIII deficiency. These combined autoantibodies neutralize FXIII, cause bleeding, and form a complex with C3, inhibiting complement activation and complement-mediated adaptive immune responses. Therefore, compromised immune responses increase host susceptibility to pathogenic Candida albicans infections. Consequently, uncontrolled exogenous fungal infections further activate platelets and cause platelet-related CD40 ligand (CD40L) release. By interacting with the CD40 on the B cell surface, the released CD40L further promotes autoreactive B cell activation to produce more autoantibodies, thereby forming a self-amplification loop for the progressive consumption of FXIII. We believe this study provides a perspective on disease pathogenesis and therapeutic guidance for better treatment of autoimmune FXIII deficiency.
- 30 September 2025
- Published by Elsevier in Food Chemistry
- Vol. 495 (Pt 3) , 146534
DoLPHiN: a proposed architecture and technical implementation of a database of structural and functional properties of natural polysaccharides with health benefits
- 30 September 2025
- Published by Elsevier in Food Chemistry
- Vol. 495 (Pt 3) , 146534
DoLPHiN: a proposed architecture and technical implementation of a database of structural and functional properties of natural polysaccharides with health benefits
- 13 November 2024
- Published by Springer Nature in Exposure and Health
- Vol. 17 (2) , 551-563
Association of Urinary Phthalate Metabolites with Lipid Profiles and the Mediating Role of Serum Globulin: A Repeated-Measures Study
- 13 November 2024
- Published by Springer Nature in Exposure and Health
- Vol. 17 (2) , 551-563
Association of Urinary Phthalate Metabolites with Lipid Profiles and the Mediating Role of Serum Globulin: A Repeated-Measures Study
- 21 September 2023
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 57 (39) , 14769
Correction to “Associations of Urinary Phthalate Metabolites with Thyroid Function and the Mediated Role of Cytokines: A Panel Study of Healthy Children”
- 21 September 2023
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 57 (39) , 14769
Correction to “Associations of Urinary Phthalate Metabolites with Thyroid Function and the Mediated Role of Cytokines: A Panel Study of Healthy Children”
- Open Access
- 30 May 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (11) , 3094
The Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan
We assessed the nearly 1-year health consequences following discharge and related risk factors of COVID-19 infection and further explored the long-term effect of COVID-19 disease severity on the risk of diabetes incidence. This prospective study included 248 COVID-19 patients discharged from Wuhan Hospital of Traditional Chinese Medicine who were followed up between 1 March and 10 June 2021. Logistic regression models were used to evaluate risk factors. The top ten symptoms were shortness of breath (30.3%), sore or dry throat (25.7%), cough (23.2%), expectoration (23.2%), body pain (22.3%), chest tightness (20.8%), palpitations (17.8%), sleep difficulties (17.0%), fatigue (16.6%), and anxiety (15.3%). Hypertension was associated with fatigue (OR = 2.51, 95% CI: 1.08, 5.80), shortness of breath (OR = 2.34, 95% CI: 1.16, 4.69), palpitations (OR = 2.82, 95% CI: 1.26, 6.31), expectoration (OR = 2.08, 95% CI: 1.01, 4.30), and sore or dry throat (OR = 2.71, 95% CI: 1.30, 5.65). Diabetes was associated with palpitations (OR = 3.22, 95% CI: 1.18, 8.81). Critical illness was associated with an increased risk of diabetes incidence after discharge (OR = 2.90, 95% CI: 1.07, 7.88), which seemed more evident in males. Long COVID-19 symptoms were common at 1-year postdischarge; hypertension and diabetes could be projected as potential risk factors. We are among the first researchers to find that critical illness is associated with incident diabetes after discharge.
- 30 May 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (11) , 3094
Open AccessThe Long-Term Effect of COVID-19 Disease Severity on Risk of Diabetes Incidence and the Near 1-Year Follow-Up Outcomes among Postdischarge Patients in Wuhan
We assessed the nearly 1-year health consequences following discharge and related risk factors of COVID-19 infection and further explored the long-term effect of COVID-19 disease severity on the risk of diabetes incidence. This prospective study included 248 COVID-19 patients discharged from Wuhan Hospital of Traditional Chinese Medicine who were followed up between 1 March and 10 June 2021. Logistic regression models were used to evaluate risk factors. The top ten symptoms were shortness of breath (30.3%), sore or dry throat (25.7%), cough (23.2%), expectoration (23.2%), body pain (22.3%), chest tightness (20.8%), palpitations (17.8%), sleep difficulties (17.0%), fatigue (16.6%), and anxiety (15.3%). Hypertension was associated with fatigue (OR = 2.51, 95% CI: 1.08, 5.80), shortness of breath (OR = 2.34, 95% CI: 1.16, 4.69), palpitations (OR = 2.82, 95% CI: 1.26, 6.31), expectoration (OR = 2.08, 95% CI: 1.01, 4.30), and sore or dry throat (OR = 2.71, 95% CI: 1.30, 5.65). Diabetes was associated with palpitations (OR = 3.22, 95% CI: 1.18, 8.81). Critical illness was associated with an increased risk of diabetes incidence after discharge (OR = 2.90, 95% CI: 1.07, 7.88), which seemed more evident in males. Long COVID-19 symptoms were common at 1-year postdischarge; hypertension and diabetes could be projected as potential risk factors. We are among the first researchers to find that critical illness is associated with incident diabetes after discharge.
- 16 May 2022
- Published by Elsevier in Environmental Research
- Vol. 212 (Pt D) , 113469
The mediating role of plasma microRNAs in the association of phthalates exposure with arterial stiffness: A panel study
- 16 May 2022
- Published by Elsevier in Environmental Research
- Vol. 212 (Pt D) , 113469
The mediating role of plasma microRNAs in the association of phthalates exposure with arterial stiffness: A panel study
- 2 March 2022
- Published by Springer Nature in Exposure and Health
- Vol. 15 (1) , 19-32
Phthalate Mixture Exposure is Associated with Elevated Blood Pressure in Chinese Children: A Panel Study
- 2 March 2022
- Published by Springer Nature in Exposure and Health
- Vol. 15 (1) , 19-32
Phthalate Mixture Exposure is Associated with Elevated Blood Pressure in Chinese Children: A Panel Study
- 1 January 2022
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 422, 126963
Urinary phthalate metabolites mixture, serum cytokines and renal function in children: A panel study
- 1 January 2022
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 422, 126963
Urinary phthalate metabolites mixture, serum cytokines and renal function in children: A panel study